Latest Regulatory Approval News

LTR Pharma’s intranasal ED treatment SPONTAN achieves peak effect up to five times faster than oral tablets, according to new peer-reviewed clinical data published in a leading European journal.

Novomatic AG has launched an unconditional A$1.00 per share cash takeover offer for all remaining shares in Ainsworth Game Technology Limited, representing a 35% premium to pre-announcement prices. The offer runs alongside a previously announced scheme and comes with unanimous support from Ainsworth's Independent Board Committee.

TG Metals reports encouraging assay results from historical stockpiles and secures approvals for in-pit drilling at its Van Uden Gold Project, aiming to unlock near-term cash flow opportunities.

Vicinity Centres has announced an ordinary unfranked dividend of AUD 0.0605 per security for the six months ending June 2025, accompanied by a Dividend Reinvestment Plan offering a 1% discount.

The Lottery Corporation reported a resilient FY25 with $3.7 billion revenue and a 3.1% dividend increase, driven by digital sales growth and strategic game refreshes despite a revenue decline from a record jackpot year.

Mount Gibson Iron reported a significant net loss for FY25 amid weaker iron ore prices but is pivoting towards gold with a major acquisition in the Northern Territory.

Mount Gibson Iron Limited reported a substantial net loss for FY2025 amid iron ore price drops and operational challenges, while announcing a strategic acquisition in the gold sector.

The Environmental Group Limited (EGL) reported a robust FY25 with revenue climbing 13.9% to $111.9 million and underlying EBITDA up 9.9%, driven by strategic acquisitions and advances in PFAS technology. The company projects further EBITDA growth of 15-20% in FY26, underpinned by expanding recurring revenue streams.

Yancoal Australia Ltd reported a sharp 61% drop in net profit for the first half of 2025, hit by falling coal prices and supply chain disruptions despite a 15% rise in production. The company declared a fully franked interim dividend and is advancing key asset deals and growth projects.

Argent BioPharma has signed a binding term sheet to acquire key assets from AusCann Group Holdings, significantly expanding its clinical pipeline, intellectual property, and European manufacturing and distribution capabilities ahead of a planned US stock exchange listing.

Wide Open Agriculture has launched a pre-feasibility study for a large-scale lupin protein facility in Western Australia, aiming to establish a new global food category and reduce production costs. This move marks a pivotal step toward commercial scale and global leadership in sustainable plant-based proteins.

Tombador Iron Limited is set to transform itself by acquiring GoviEx Uranium, creating a new ASX-listed uranium company focused on Zambia’s Muntanga Project. This deal includes a significant capital raise and board overhaul, aiming for a November 2025 completion.